Rephonic
Artwork for The Readout Loud

The Readout Loud

STAT
FDA
Vertex Pharmaceuticals
Venture Capital
CRISPR
Gilead Sciences
Rick Gonzalez
Obesity Treatments
Opioid Addiction
Biotechnology
Sanofi
Clinical Trials
Abbvie
Pfizer
Aduhelm
Drug Development
Biotech Financing
Eli Lilly
Car-T
Oncology
Casgevi

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

PublishesWeeklyEpisodes381Founded8 years ago
Number of ListenersCategory
Business

Listen to this Podcast

Artwork for The Readout Loud

Latest Episodes

On a jam-packed show, your co-hosts, minus the vacationing Allison DeAngelis, chat with STAT’s D.C. correspondent Lizzy Lawrence about a slow-boiling feud between Vinay Prasad, the head of the FDA’s biologics and vaccine branch, and his staff that ha... more

Has BridgeBio’s business model worked? How are executives at Moderna dealing with the company’s slump? And who will the hosts dress up as for Halloween?

We discuss all that on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. We... more

Can Trump take credit for North Carolina's booming biopharma industry? Which drugs could get a shortcut to the market? And who wore a tuxedo to the STAT Summit?

We discuss all that and more in the latest episode of "The Readout LOUD."

Elaine is out ... more

On this week’s episode of “The Readout LOUD”: an interview with veteran biotech executive and company founder Clive Meanwell. Pfizer recently acquired one of Meanwell’s companies, the obesity drug developer Metsera, for just under $5 billion.

Meanwe... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more
Tradeoffs
TradeoffsTradeoffs

Recent Guests

Neil Kumar
CEO of BridgeBio
BridgeBio
Episode: 376: BridgeBio’s great week and Moderna’s unraveling
Dietmar Berger
Chief Medical Officer at Gilead Sciences
Gilead Sciences
Episode: 375: Startups push the FDA and biotech booms in North Carolina
Nobuar Afeyan
Co-founder of Moderna
Moderna
Episode: 375: Startups push the FDA and biotech booms in North Carolina
Dr. Dietmar Berger
Chief Medical Officer at Gilead Sciences
Gilead Sciences
Episode: 373: Party in biotech land and AstraZeneca’s miscalculation
Stacie Dusetzina
Health policy researcher
Vanderbilt University Medical Center
Episode: 372: A pharma C-suite shakeup and Trump's deal with Pfizer
Matt Kapusta
CEO of UniQure
UniQure
Episode: 371: A gene therapy success in Huntington's and Trump's autism announcement
Ari Ne'eman
Assistant professor of health policy and management at Harvard School of Public Health, former executive director of the Autistic Self Advocacy Network
Harvard School of Public Health
Episode: 371: A gene therapy success in Huntington's and Trump's autism announcement
Drew Joseph
Colleague reporting from London on UK life sciences
STAT
Episode: 370: Pharma sours on the U.K., plus biotech M&A's quiet roll
Mike Rea
Pharma consultant and head of the UK pharma consultancy, Idea Pharma, focusing on R&D productivity and drug development.
Idea Pharma
Episode: 369: Trump, Chinese biotech, and an industry career reshaped by illness

Hosts

Allison DeAngelis
Co-host providing insights on biotech news with an engaging style and a background in health reporting.
Adam Feuerstein
Co-host known for in-depth analyses on pharmaceutical and biotech topics with a journalistic lens.
Elaine Chen
Co-host with a focus on articulate discussions related to biotech and public health reporting, enhancing audience engagement.

Reviews

4.6 out of 5 stars from 562 ratings
  • Please reboot the old quality bar

    This podcast was a gold mine a few years back. Really miss that run you had. Adam is good but even he was better back when surrounded with higher caliber cohosts.

    Apple Podcasts
    3
    freedomtochoose
    United States2 months ago
  • Way Too Political

    Like others have mentioned, this podcast has become way too political in how it covers this sector. Please cover the content with a little bit more neutrality, because it erodes the credibility of the hosts.

    Apple Podcasts
    2
    Kitten Kitten Star
    United States3 months ago
  • Your bias is showing

    Disappointing that your reporting of the DHHS staff cuts (and the new administration as a whole) is so one-sided. How about trying a neutral approach? Consider that some of your listeners have common sense.

    Apple Podcasts
    1
    bennoanddixie
    United States7 months ago
  • The best podcast out there

    This podcast will blow your mind, five stars

    Apple Podcasts
    5
    MilesMcKinley
    United States9 months ago
  • Great podcast

    It helps me catch up on the biotech news every week! Very informative.

    Apple Podcasts
    5
    HB4000
    United States9 months ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Hosts have a good grasp of the subject matter, although occasional critiques arise regarding their presentation style.
Informative and engaging discussions on biotech news, though some listeners wish for more neutrality in coverage.
There are mixed feelings about the hosts' biases, with some appreciating the thorough analysis while others seek a more balanced approach.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#138
Switzerland/Business
Apple Podcasts
#144
Ireland/Business
Apple Podcasts
#241
South Korea/Business

Talking Points

Recent interactions between the hosts and their guests.

376: BridgeBio’s great week and Moderna’s unraveling
Q: Is his job as CEO secure?
Jason shares that Stéphane Boncel's job seems secure given his significant role in building Moderna, despite the current difficulties.
376: BridgeBio’s great week and Moderna’s unraveling
Q: With this interim data showing significant benefits, what's your thinking with that?
Neil discusses the surprising efficacy of their drug in improving muscle function and their considerations for full approval due to positive trial data.
376: BridgeBio’s great week and Moderna’s unraveling
Q: Neil, how has your week been? And what do you do to celebrate something like this?
Neil expresses feelings of privilege and gratitude, stating that they plan to take a moment to celebrate their successes despite being busy with work.
374: Veteran biotech executive Clive Meanwell on drug pricing and the obesity market
Q: Do you think that there is a, antagonism is too strong of a word, but I think that we all sense that what the pharma industry is doing doesn't really seem to be aligning with what everyday people are looking for a lot of the time?
Meanwell acknowledges that while big pharma serves some needs effectively, there is a growing necessity for broader population health initiatives and better alignment with everyday consumer needs.
374: Veteran biotech executive Clive Meanwell on drug pricing and the obesity market
Q: So Clive, congrats on the acquisition. As we said, Pfizer is buying your company Metsera for just under $5 billion. We'd also note that back in 2019, Novartis bought your previous company, the Medicines Company, for a touch under $10 billion. So I wonder, do you love all of your takeouts equally, or does one stand out more than the other?
Meanwell reflects that each acquisition is bittersweet and emphasizes the importance of the acquired company being able to continue producing value for shareholders and patients.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Readout Loud

What is The Readout Loud about and what kind of topics does it cover?

Focused on the dynamic world of biotechnology, this podcast provides a critical examination of the latest industry news and developments. Regularly addressing significant events and trends, conversations often spotlight the implications of leadership changes, drug approvals, and pivotal public health discussions. The hosts navigate the complexities of biotech investments, regulatory hurdles, and emerging medical advancements all while emphasizing the human stories behind the innovations in the field.

Notable for its blend of industry expertise and engaging dialogue, the podcast features insights from both hosts and expert guests, effectively making complex topics accessible to a broader audience. The unique mix of scientific scrutiny and p... more

Where can I find podcast stats for The Readout Loud?

Rephonic provides a wide range of podcast stats for The Readout Loud. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Readout Loud and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Readout Loud get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Readout Loud, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Readout Loud?

Rephonic provides comprehensive predictive audience data for The Readout Loud, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Readout Loud have?

To see how many followers or subscribers The Readout Loud has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Readout Loud?

These podcasts share a similar audience with The Readout Loud:

1. BioCentury This Week
2. Biotech Hangout
3. The Long Run with Luke Timmerman
4. Business Of Biotech
5. Tradeoffs

How many episodes of The Readout Loud are there?

The Readout Loud launched 8 years ago and published 381 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Readout Loud?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Readout Loud?

Rephonic pulls ratings and reviews for The Readout Loud from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Readout Loud?

Rephonic provides full transcripts for episodes of The Readout Loud. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Readout Loud?

Recent guests on The Readout Loud include:

1. Neil Kumar
2. Dietmar Berger
3. Nobuar Afeyan
4. Dr. Dietmar Berger
5. Stacie Dusetzina
6. Matt Kapusta
7. Ari Ne'eman
8. Drew Joseph

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days